CytoDyn Inc: Ticker Symbol CYDY
investorials.com CytoDyn Inc., ticker symbol CYDY, is a biotechnology company focused on combatting infection with immunodeficiency viruses with three products in its clinical pipeline for HIV and FIV. Its lead product, PRO 140, is a monoclonal antibody designed to block HIV from entering cells, thereby inhibiting the chronic condition. Since there #39;s no chemicals involved, there are no toxicity or drug resistance issues that are usually associated with drug therapies. The treatment has already passed Phase IA and Phase IIA clinical trials, making it the most advanced experimental monoclonal antibody for HIV treatment. For more information, visit the company #39;s Investorial at http://www.investorials.com/companies/cydy.From:InvestorialsViews:1 0ratingsTime:00:55More inEducation
Read the original here:
CytoDyn Inc: Ticker Symbol CYDY - Video
Recommendation and review posted by G. Smith
